Human cytomegalovirus infection increases mitochondrial biogenesis

Mitochondrion

Volumn 11, Issue 6, 2011, Pages 935-945

  Kaarbø, Mari ^a   Ager Wick, Eirill ^a,b   Osenbroch, Pia Øistad ^a   Kilander, Anette ^a,c   Skinnes, Ragnhild ^a   Müller, Fredrik ^a   Eide, Lars ^a  

^a UNIVERSITY OF OSLO   (Norway)

^b NORWEGIAN UNIVERSITY OF LIFE SCIENCES   (Norway)

^c NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

Author keywords

CMV; Mitochondrial biogenesis; PUL37x1; Supercomplex; VMIA

Indexed keywords

CHLORAMPHENICOL; MESSENGER RNA; MITOCHONDRIAL DNA; PROTEIN PUL37X1; UNCLASSIFIED DRUG; VIRUS PROTEIN;

APOPTOSIS; ARTICLE; BIOGENESIS; CELL ACTIVATION; CELL ACTIVITY; CELL VIABILITY; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; FIBROBLAST; FLOW CYTOMETRY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN CYTOMEGALOVIRUS; IN VITRO STUDY; MITOCHONDRIAL RESPIRATION; MITOCHONDRION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; VIRUS REPLICATION; VIRUS TITRATION;

CELL RESPIRATION; CYTOMEGALOVIRUS INFECTIONS; FIBROBLASTS; HUMANS; IMMEDIATE-EARLY PROTEINS; MITOCHONDRIA;

HUMAN HERPESVIRUS 5;

EID: 82755182641     PISSN: 15677249     EISSN: 18728278     Source Type: Journal    
DOI: 10.1016/j.mito.2011.08.008     Document Type: Article

References (61)

1. Acin-Perez R., Fernandez-Silva P., Peleato M.L., Perez-Martos A., Enriquez J.A. Respiratory active mitochondrial supercomplexes. Mol. Cell 2008, 32:529-539.
2. Andreasson H., Gyllensten U., Allen M. Real-time DNA quantification of nuclear and mitochondrial DNA in forensic analysis. Biotechniques 2002, 33:402-411.
3. Antes A., Tappin I., Chung S., Lim R., Lu B., Parrott A.M., Hill H.Z., Suzuki C.K., Lee C.G. Differential regulation of full-length genome and a single-stranded 7S DNA along the cell cycle in human mitochondria. Nucleic Acids Res. 2010, 38:6466-6476.
4. Aquilano K., Vigilanza P., Baldelli S., Pagliei B., Rotilio G., Ciriolo M.R. Peroxisome proliferator-activated receptor gamma co-activator 1alpha (PGC-1alpha) and sirtuin 1 (SIRT1) reside in mitochondria: possible direct function in mitochondrial biogenesis. J. Biol. Chem. 2010, 285:21590-21599.
5. Arnoult D., Bartle L.M., Skaletskaya A., Poncet D., Zamzami N., Park P.U., Sharpe J., Youle R.J., Goldmacher V.S. Cytomegalovirus cell death suppressor vMIA blocks Bax- but not Bak-mediated apoptosis by binding and sequestering Bax at mitochondria. Proc. Natl. Acad. Sci. U. S. A. 2004, 101:7988-7993.
6. Barja G. Endogenous oxidative stress: relationship to aging, longevity and caloric restriction. Ageing Res. Rev. 2002, 1:397-411.
7. Bozidis P., Williamson C.D., Colberg-Poley A.M. Mitochondrial and secretory human cytomegalovirus UL37 proteins traffic into mitochondrion-associated membranes of human cells. J. Virol. 2008, 82:2715-2726.
8. Bozidis P., Williamson C.D., Wong D.S., Colberg-Poley A.M. Trafficking of UL37 proteins into mitochondrion-associated membranes during permissive human cytomegalovirus infection. J. Virol. 2010, 84:7898-7903.
9. Chambers J.W., Maguire T.G., Alwine J.C. Glutamine metabolism is essential for human cytomegalovirus infection. J. Virol. 2010, 84:1867-1873.
10. Colberg-Poley A.M., Santomenna L.D., Harlow P.P., Benfield P.A., Tenney D.J. Human cytomegalovirus US3 and UL36-38 immediate-early proteins regulate gene expression. J. Virol. 1992, 66:95-105.
11. Colberg-Poley A.M., Huang L., Soltero V.E., Iskenderian A.C., Schumacher R.F., Anders D.G. The acidic domain of pUL37x1 and gpUL37 plays a key role in transactivation of HCMV DNA replication gene promoter constructions. Virology 1998, 246:400-408.
12. Datsenko K.A., Wanner B.L. One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products. Proc. Natl. Acad. Sci. U. S. A. 2000, 97:6640-6645.
13. D'Aurelio M., Gajewski C.D., Lenaz G., Manfredi G. Respiratory chain supercomplexes set the threshold for respiration defects in human mtDNA mutant cybrids. Hum. Mol. Genet. 2006, 15:2157-2169.
14. Dittmer D., Mocarski E.S. Human cytomegalovirus infection inhibits G1/S transition. J. Virol. 1997, 71:1629-1634.
15. Dunn W., Chou C., Li H., Hai R., Patterson D., Stolc V., Zhu H., Liu F. Functional profiling of a human cytomegalovirus genome. Proc. Natl. Acad. Sci. U. S. A. 2003, 100:14223-14228.
16. Everett H., McFadden G. Apoptosis: an innate immune response to virus infection. Trends Microbiol. 1999, 7:160-165.
17. Evers D.L., Wang X., Huang E.S. Cellular stress and signal transduction responses to human cytomegalovirus infection. Microbes Infect. 2004, 6:1084-1093.
18. Fortunato E.A., McElroy A.K., Sanchez I., Spector D.H. Exploitation of cellular signaling and regulatory pathways by human cytomegalovirus. Trends Microbiol. 2000, 8:111-119.
19. Furukawa T., Sakuma S., Plotkin S.A. Human cytomegalovirus infection of WI-38 cells stimulates mitochondrial DNA synthesis. Nature 1976, 262:414-416.
20. Goldmacher V.S., Bartle L.M., Skaletskaya A., Dionne C.A., Kedersha N.L., Vater C.A., Han J.W., Lutz R.J., Watanabe S., Cahir McFarland E.D., Kieff E.D., Mocarski E.S., Chittenden T. A cytomegalovirus-encoded mitochondria-localized inhibitor of apoptosis structurally unrelated to Bcl-2. Proc. Natl. Acad. Sci. U. S. A. 1999, 96:12536-12541.
21. Hahn W., Ho S.H., Jeong J.G., Hahn E.Y., Kim S., Yu S.S., Kim S., Kim J.M. Viral vector-mediated transduction of a modified thrombospondin-2 cDNA inhibits tumor growth and angiogenesis. Gene Ther. 2004, 11:739-745.
22. Halestrap A.P. What is the mitochondrial permeability transition pore?. J. Mol. Cell. Cardiol. 2009, 46:821-831.
23. Hertel L., Mocarski E.S. Global analysis of host cell gene expression late during cytomegalovirus infection reveals extensive dysregulation of cell cycle gene expression and induction of Pseudomitosis independent of US28 function. J. Virol. 2004, 78:11988-12011.
24. Herzig S., Long F., Jhala U.S., Hedrick S., Quinn R., Bauer A., Rudolph D., Schutz G., Yoon C., Puigserver P., Spiegelman B., Montminy M. CREB regulates hepatic gluconeogenesis through the coactivator PGC-1. Nature 2001, 413:179-183.
25. Hjelmesaeth J., Sagedal S., Hartmann A., Rollag H., Egeland T., Hagen M., Nordal K.P., Jenssen T. Asymptomatic cytomegalovirus infection is associated with increased risk of new-onset diabetes mellitus and impaired insulin release after renal transplantation. Diabetologia 2004, 47:1550-1556.
26. Hjelmesaeth J., Muller F., Jenssen T., Rollag H., Sagedal S., Hartmann A. Is there a link between cytomegalovirus infection and new-onset posttransplantation diabetes mellitus? Potential mechanisms of virus induced beta-cell damage. Nephrol. Dial. Transplant. 2005, 20:2311-2315.
27. Jager S., Handschin C., St-Pierre J., Spiegelman B.M. AMP-activated protein kinase (AMPK) action in skeletal muscle via direct phosphorylation of PGC-1alpha. Proc. Natl. Acad. Sci. U. S. A. 2007, 104:12017-12022.
28. Kearns A.M., Guiver M., James V., King J. Development and evaluation of a real-time quantitative PCR for the detection of human cytomegalovirus. J. Virol. Methods 2001, 95:121-131.
29. Liu B., Stinski M.F. Human cytomegalovirus contains a tegument protein that enhances transcription from promoters with upstream ATF and AP-1 cis-acting elements. J. Virol. 1992, 66:4434-4444.
30. Mavinakere M.S., Colberg-Poley A.M. Dual targeting of the human cytomegalovirus UL37 exon 1 protein during permissive infection. J. Gen. Virol. 2004, 85:323-329.
31. McCormick A.L., Smith V.L., Chow D., Mocarski E.S. Disruption of mitochondrial networks by the human cytomegalovirus UL37 gene product viral mitochondrion-localized inhibitor of apoptosis. J. Virol. 2003, 77:631-641.
32. McCormick A.L., Roback L., Mocarski E.S. HtrA2/Omi terminates cytomegalovirus infection and is controlled by the viral mitochondrial inhibitor of apoptosis (vMIA). PLoS Pathog. 2008, 4:e1000063.
33. Munger J., Bajad S.U., Coller H.A., Shenk T., Rabinowitz J.D. Dynamics of the cellular metabolome during human cytomegalovirus infection. PLoS Pathog. 2006, 2:e132.
34. Nassiri M.R., Gilloteaux J., Taichman R.S., Drach J.C. Ultrastructural aspects of cytomegalovirus-infected fibroblastic stromal cells of human bone marrow. Tissue Cell 1998, 30:398-406.
35. Poncet D., Larochette N., Pauleau A.L., Boya P., Jalil A.A., Cartron P.F., Vallette F., Schnebelen C., Bartle L.M., Skaletskaya A., Boutolleau D., Martinou J.C., Goldmacher V.S., Kroemer G., Zamzami N. An anti-apoptotic viral protein that recruits Bax to mitochondria. J. Biol. Chem. 2004, 279:22605-22614.
36. Poncet D., Pauleau A.L., Szabadkai G., Vozza A., Scholz S.R., Le B.M., Briere J.J., Jalil A., Le M.R., Brenner C., Hahn G., Wittig I., Schagger H., Lemaire C., Bianchi K., Souquere S., Pierron G., Rustin P., Goldmacher V.S., Rizzuto R., Palmieri F., Kroemer G. Cytopathic effects of the cytomegalovirus-encoded apoptosis inhibitory protein vMIA. J. Cell Biol. 2006, 174:985-996.
37. Puigserver P., Spiegelman B.M. Peroxisome proliferator-activated receptor-gamma coactivator 1 alpha (PGC-1 alpha): transcriptional coactivator and metabolic regulator. Endocr. Rev. 2003, 24:78-90.
38. Ranneberg-Nilsen T., Dale H.A., Luna L., Slettebakk R., Sundheim O., Rollag H., Bjoras M. Characterization of human cytomegalovirus uracil DNA glycosylase (UL114) and its interaction with polymerase processivity factor (UL44). J. Mol. Biol. 2008, 381:276-288.
39. Reboredo M., Greaves R.F., Hahn G. Human cytomegalovirus proteins encoded by UL37 exon 1 protect infected fibroblasts against virus-induced apoptosis and are required for efficient virus replication. J. Gen. Virol. 2004, 85:3555-3567.
40. Reeves M.B., Davies A.A., McSharry B.P., Wilkinson G.W., Sinclair J.H. Complex I binding by a virally encoded RNA regulates mitochondria-induced cell death. Science 2007, 316:1345-1348.
41. Rizzuto R., Pinton P., Carrington W., Fay F.S., Fogarty K.E., Lifshitz L.M., Tuft R.A., Pozzan T. Close contacts with the endoplasmic reticulum as determinants of mitochondrial Ca2+ responses. Science 1998, 280:1763-1766.
42. Schagger H. Respiratory chain supercomplexes of mitochondria and bacteria. Biochim. Biophys. Acta 2002, 1555:154-159.
43. Seo J.Y., Yaneva R., Hinson E.R., Cresswell P. Human cytomegalovirus directly induces the antiviral protein viperin to enhance infectivity. Science 2011, 332:1093-1097.
44. Sharon-Friling R., Goodhouse J., Colberg-Poley A.M., Shenk T. Human cytomegalovirus pUL37x1 induces the release of endoplasmic reticulum calcium stores. Proc. Natl. Acad. Sci. U. S. A. 2006, 103:19117-19122.
45. Sheridan C., Delivani P., Cullen S.P., Martin S.J. Bax- or Bak-induced mitochondrial fission can be uncoupled from cytochrome C release. Mol. Cell 2008, 31:570-585.
46. Skaletskaya A., Bartle L.M., Chittenden T., McCormick A.L., Mocarski E.S., Goldmacher V.S. A cytomegalovirus-encoded inhibitor of apoptosis that suppresses caspase-8 activation. Proc. Natl. Acad. Sci. U. S. A. 2001, 98:7829-7834.
47. Speir E., Shibutani T., Yu Z.X., Ferrans V., Epstein S.E. Role of reactive oxygen intermediates in cytomegalovirus gene expression and in the response of human smooth muscle cells to viral infection. Circ. Res. 1996, 79:1143-1152.
48. Starkov A.A., Fiskum G., Chinopoulos C., Lorenzo B.J., Browne S.E., Patel M.S., Beal M.F. Mitochondrial alpha-ketoglutarate dehydrogenase complex generates reactive oxygen species. J. Neurosci. 2004, 24:7779-7788.
49. Stiban J., Caputo L., Colombini M. Ceramide synthesis in the endoplasmic reticulum can permeabilize mitochondria to proapoptotic proteins. J. Lipid Res. 2008, 49:625-634.
50. Tenney D.J., Colberg-Poley A.M. RNA analysis and isolation of cDNAs derived from the human cytomegalovirus immediate-early region at 0.24 map units. Intervirology 1990, 31:203-214.
51. Tenney D.J., Colberg-Poley A.M. Expression of the human cytomegalovirus UL36-38 immediate early region during permissive infection. Virology 1991, 182:199-210.
52. Tenney D.J., Colberg-Poley A.M. Human cytomegalovirus UL36-38 and US3 immediate-early genes: temporally regulated expression of nuclear, cytoplasmic, and polysome-associated transcripts during infection. J. Virol. 1991, 65:6724-6734.
53. Terhune S., Torigoi E., Moorman N., Silva M., Qian Z., Shenk T., Yu D. Human cytomegalovirus UL38 protein blocks apoptosis. J. Virol. 2007, 81:3109-3123.
54. van der Werf N., Kroese F.G., Rozing J., Hillebrands J.L. Viral infections as potential triggers of type 1 diabetes. Diabetes Metab. Res. Rev. 2007, 23:169-183.
55. Wallace D.C. Animal models for mitochondrial disease. Methods Mol. Biol. 2002, 197:3-54.
56. Wiebusch L., Truss M., Hagemeier C. Inhibition of human cytomegalovirus replication by small interfering RNAs. J. Gen. Virol. 2004, 85:179-184.
57. Williamson C.D., Colberg-Poley A.M. Intracellular sorting signals for sequential trafficking of human cytomegalovirus UL37 proteins to the endoplasmic reticulum and mitochondria. J. Virol. 2010, 84:6400-6409.
58. Wittig I., Braun H.P., Schagger H. Blue native PAGE. Nat. Protoc. 2006, 1:418-428.
59. Xuan B., Qian Z., Torigoi E., Yu D. Human cytomegalovirus protein pUL38 induces ATF4 expression, inhibits persistent JNK phosphorylation, and suppresses endoplasmic reticulum stress-induced cell death. J. Virol. 2009, 83:3463-3474.
60. Yadava N., Nicholls D.G. Spare respiratory capacity rather than oxidative stress regulates glutamate excitotoxicity after partial respiratory inhibition of mitochondrial complex I with rotenone. J. Neurosci. 2007, 27:7310-7317.
61. Yoon J.C., Puigserver P., Chen G., Donovan J., Wu Z., Rhee J., Adelmant G., Stafford J., Kahn C.R., Granner D.K., Newgard C.B., Spiegelman B.M. Control of hepatic gluconeogenesis through the transcriptional coactivator PGC-1. Nature 2001, 413:131-138.